115 related articles for article (PubMed ID: 31594785)
21. Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation.
Pemovska T; Johnson E; Kontro M; Repasky GA; Chen J; Wells P; Cronin CN; McTigue M; Kallioniemi O; Porkka K; Murray BW; Wennerberg K
Nature; 2015 Mar; 519(7541):102-5. PubMed ID: 25686603
[TBL] [Abstract][Full Text] [Related]
22. BCR-ABL1 tyrosine kinase sustained MECOM expression in chronic myeloid leukaemia.
Roy S; Jørgensen HG; Roy P; Abed El Baky M; Melo JV; Strathdee G; Holyoake TL; Bartholomew C
Br J Haematol; 2012 May; 157(4):446-56. PubMed ID: 22372463
[TBL] [Abstract][Full Text] [Related]
23. Kaposi's sarcoma in a patient treated with imatinib mesylate for chronic myeloid leukemia.
Campione E; Diluvio L; Paternò EJ; Di Marcantonio D; Francesconi A; Terrinoni A; Orlandi A; Chimenti S
Clin Ther; 2009 Nov; 31(11):2565-9. PubMed ID: 20110001
[TBL] [Abstract][Full Text] [Related]
24. Bullous Sweet syndrome as a presentation of chronic myelogenous leukaemia.
Abbas SW; Shah Z; Shaikh MU
BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36455980
[TBL] [Abstract][Full Text] [Related]
25. Antibody arrays identify protein-protein interactions in chronic myeloid leukaemia.
Patel H; Nteliopoulos G; Nikolakopoulou Z; Jackson A; Gordon MY
Br J Haematol; 2011 Mar; 152(5):611-4. PubMed ID: 21314824
[TBL] [Abstract][Full Text] [Related]
26. Composite chronic myeloid leukemia and essential thrombocythemia with BCR-ABL1 fusion and CALR mutation.
Xia D; Hsi ED; Dal Cin P; Hasserjian RP
Am J Hematol; 2019 Apr; 94(4):504-505. PubMed ID: 30105753
[No Abstract] [Full Text] [Related]
27. Colony-Forming Cell Assay Detecting the Co-Expression of JAK2V617F and BCR-ABL1 in the Same Clone: A Case Report.
Tirrò E; Stella S; Massimino M; Zammit V; Pennisi MS; Vitale SR; Romano C; Di Gregorio S; Puma A; Di Raimondo F; Stagno F; Manzella L
Acta Haematol; 2019; 141(4):261-267. PubMed ID: 30965317
[TBL] [Abstract][Full Text] [Related]
28. Chronic myeloid leukaemia, BCR-ABL1-positive, in accelerated phase with marked eosinophilia with eosinophil atypia.
Richardson AI; Skikne BS; Woodroof J
Br J Haematol; 2020 Mar; 188(5):599. PubMed ID: 32032978
[No Abstract] [Full Text] [Related]
29. Chronic myeloid leukaemia: The dangers of not knowing your BCR-ABL1 transcript.
Sharplin K; Altamura H; Taylor K; Wellwood J; Taylor D; Branford S
Leuk Res; 2019 Dec; 87():106231. PubMed ID: 31639634
[No Abstract] [Full Text] [Related]
30. Effect of low-level BCR-ABL1 kinase domain mutations identified by next-generation sequencing in patients with chronic myeloid leukaemia: a population-based study.
Kizilors A; Crisà E; Lea N; Passera R; Mian S; Anwar J; Best S; Nicolini FE; Ireland R; Aldouri M; Pocock C; Corbett T; Gale R; Bart-Smith E; Weston-Smith S; Wykes C; Kulasekararaj A; Jackson S; Harrington P; McLornan D; Raj K; Pagliuca A; Mufti GJ; de Lavallade H
Lancet Haematol; 2019 May; 6(5):e276-e284. PubMed ID: 31036317
[TBL] [Abstract][Full Text] [Related]
31. Dual inhibition of ras and bcr-abl signalling pathways in chronic myeloid leukaemia: a phase I/II study in patients in complete haematological remission.
Pavlu J; Andreasson C; Chuah C; Kaeda J; Goldman JM; Apperley JF; Marin D
Br J Haematol; 2007 Jun; 137(5):423-8. PubMed ID: 17428238
[TBL] [Abstract][Full Text] [Related]
32. RAG enhances BCR-ABL1-positive leukemic cell growth through its endonuclease activity in vitro and in vivo.
Yuan M; Wang Y; Qin M; Zhao X; Chen X; Li D; Miao Y; Otieno Odhiambo W; Liu H; Ma Y; Ji Y
Cancer Sci; 2021 Jul; 112(7):2679-2691. PubMed ID: 33949040
[TBL] [Abstract][Full Text] [Related]
33. Prognosis for patients with CML and >10% BCR-ABL1 after 3 months of imatinib depends on the rate of BCR-ABL1 decline.
Branford S; Yeung DT; Parker WT; Roberts ND; Purins L; Braley JA; Altamura HK; Yeoman AL; Georgievski J; Jamison BA; Phillis S; Donaldson Z; Leong M; Fletcher L; Seymour JF; Grigg AP; Ross DM; Hughes TP
Blood; 2014 Jul; 124(4):511-8. PubMed ID: 24859364
[TBL] [Abstract][Full Text] [Related]
34. Role of NOX2 for leukaemic expansion in a murine model of BCR-ABL1
Grauers Wiktorin H; Nilsson T; Aydin E; Hellstrand K; Palmqvist L; Martner A
Br J Haematol; 2018 Jul; 182(2):290-294. PubMed ID: 28542840
[No Abstract] [Full Text] [Related]
35. Variant e19a2 BCR-ABL1 fusion transcript in typical chronic myeloid leukemia.
Tutulan-Cunita AC; Chirieac SM; Mocanu G; Luca C; Costache M; Lungeanu A; Arghir A
Clin Lab; 2011; 57(9-10):785-8. PubMed ID: 22029197
[TBL] [Abstract][Full Text] [Related]
36. Abnormal chromatin clumping in granulocytes in a case of Ph1-negative, BCR-ABL rearrangement positive, haematologically atypical chronic myeloid leukaemia (CML).
Tertian G; Misrahi M; Diallo D; Mielot F; Leonard C; Salmeron S; Tchernia G
Nouv Rev Fr Hematol (1978); 1995; 37(4):245-7. PubMed ID: 8904205
[TBL] [Abstract][Full Text] [Related]
37. Philadelphia negative BCR-ABL positive chronic myeloid leukemia mimicking juvenile chronic myeloid leukemia in a 2-year-old child.
Mahon FX; Labouyrie E; Aurich-Costa J; Dastugue N; Micheau M; Bady C; Perel Y; Bilhou-Nabera C; Reiffers J; Bernard P
Leuk Lymphoma; 1997 Aug; 26(5-6):615-9. PubMed ID: 9389369
[TBL] [Abstract][Full Text] [Related]
38. Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm.
Salem A; Loghavi S; Tang G; Huh YO; Jabbour EJ; Kantarjian H; Wang W; Hu S; Luthra R; Medeiros LJ; Khoury JD
Am J Hematol; 2017 Jun; 92(6):520-528. PubMed ID: 28253536
[TBL] [Abstract][Full Text] [Related]
39. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
Beran M; Cao X; Estrov Z; Jeha S; Jin G; O'Brien S; Talpaz M; Arlinghaus RB; Lydon NB; Kantarjian H
Clin Cancer Res; 1998 Jul; 4(7):1661-72. PubMed ID: 9676840
[TBL] [Abstract][Full Text] [Related]
40. BCR-ABL promotes PTEN downregulation in chronic myeloid leukemia.
Panuzzo C; Crivellaro S; Carrà G; Guerrasio A; Saglio G; Morotti A
PLoS One; 2014; 9(10):e110682. PubMed ID: 25343485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
